217 related articles for article (PubMed ID: 8864833)
1. Placental and fetal cardiac laminin are targets for cross-reacting autoantibodies from mothers of children with congenital heart block.
Horsfall AC; Li JM; Maini RN
J Autoimmun; 1996 Aug; 9(4):561-8. PubMed ID: 8864833
[TBL] [Abstract][Full Text] [Related]
2. Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin--a role in the pathogenesis of congenital heart block?
Li JM; Horsfall AC; Maini RN
Clin Exp Immunol; 1995 Mar; 99(3):316-24. PubMed ID: 7882552
[TBL] [Abstract][Full Text] [Related]
3. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells.
Neufing PJ; Clancy RM; Jackson MW; Tran HB; Buyon JP; Gordon TP
Arthritis Rheum; 2005 Dec; 52(12):3934-42. PubMed ID: 16320341
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive maternal autoantibodies and congenital heart block.
Horsfall AC; Rose LM
J Autoimmun; 1992 Aug; 5(4):479-93. PubMed ID: 1384530
[TBL] [Abstract][Full Text] [Related]
5. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
6. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus.
Tran HB; Macardle PJ; Hiscock J; Cavill D; Bradley J; Buyon JP; Gordon TP
Arthritis Rheum; 2002 Jun; 46(6):1572-9. PubMed ID: 12115188
[TBL] [Abstract][Full Text] [Related]
7. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of antibodies immunoadsorbed to laminin with recombinant human La (SS-B) protein.
Chang SH; Huh MS; Kim HR; Kim IS; Kim S; Lee JS; Semsei I; Grölz D; Bachmann M
J Autoimmun; 1998 Apr; 11(2):163-7. PubMed ID: 9650095
[TBL] [Abstract][Full Text] [Related]
9. Subcellular redistribution of la/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block.
Tran HB; Ohlsson M; Beroukas D; Hiscock J; Bradley J; Buyon JP; Gordon TP
Arthritis Rheum; 2002 Jan; 46(1):202-8. PubMed ID: 11817591
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of mothers of children with complete congenital heart block.
Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies associated with congenital heart block.
Salomonsson S; Strandberg L
Scand J Immunol; 2010 Sep; 72(3):185-8. PubMed ID: 20696014
[TBL] [Abstract][Full Text] [Related]
12. Serologic follow-up of children born to mothers with Ro/SSA autoantibodies.
Klauninger R; Skog A; Horvath L; Winqvist O; Edner A; Bremme K; Sonesson SE; Wahren-Herlenius M
Lupus; 2009 Aug; 18(9):792-8. PubMed ID: 19578103
[TBL] [Abstract][Full Text] [Related]
13. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block.
Li JM; Fan WS; Horsfall AC; Anderson AC; Rigby S; Larsson E; Venables PJ
Clin Exp Immunol; 1996 Jun; 104(3):388-93. PubMed ID: 9099920
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model.
Ambrosi A; Dzikaite V; Park J; Strandberg L; Kuchroo VK; Herlenius E; Wahren-Herlenius M
Ann Rheum Dis; 2012 Mar; 71(3):448-54. PubMed ID: 22084395
[TBL] [Abstract][Full Text] [Related]
15. Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block.
Buyon JP; Clancy RM
Lupus; 2008 Feb; 17(2):86-90. PubMed ID: 18250129
[TBL] [Abstract][Full Text] [Related]
16. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
[TBL] [Abstract][Full Text] [Related]
17. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.
Salomonsson S; Sonesson SE; Ottosson L; Muhallab S; Olsson T; Sunnerhagen M; Kuchroo VK; Thorén P; Herlenius E; Wahren-Herlenius M
J Exp Med; 2005 Jan; 201(1):11-7. PubMed ID: 15630133
[TBL] [Abstract][Full Text] [Related]
18. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen.
Tran HB; Cavill D; Buyon JP; Gordon TP
Arthritis Rheum; 2004 Jan; 50(1):337-8; author reply 338. PubMed ID: 14730639
[No Abstract] [Full Text] [Related]
20. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
